Vericel Reduces MACI Guide on Patient Flow Downturn
The company's MACI product grew nearly 30% in the third quarter of 2022, but patient flow disruptions brought a guidance reduction. Nov 11, 2022
Globus Stabilizes At High Single Digit Growth
The company grew just over 10% in third quarter of 2022, driven by competitive rep conversions and robotic pull-through. Nov 11, 2022
ATEC’s Sector-Leading Growth Validates Approach
The company grew over 40% in 3Q22, driven by its accelerating lateral surgery business and enabling technologies like EOS. Nov 09, 2022
Smith+Nephew Records Early Wins in Ortho Turnaround
Excluding the impact of foreign currency, the company grew in the mid-single digits as elective procedures recovered in the U.S. Nov 08, 2022
Orthofix’s Strategic Investments Driving Growth
The company grew in the mid-single digits at constant currency for 3Q22, driven by investments in its commercial channel. Nov 08, 2022
Enovis Continues Organic Growth Ramp
The company's reported orthopedic sales grew by nearly 20% in 3Q22, driven by double-digit growth across its product lines. Nov 07, 2022
Conformis Transformation Taking Longer Than Expected
The company declined in the low-single digits for 3Q22 as Conformis' business model transition meets roadblocks. Nov 07, 2022
OrthoPediatrics Lowers Guidance on RSV Disruption
The company lowered its 2022 guidance despite nearly 40% growth in 3Q as RSV infections reduce pediatric surgical capacity. Nov 04, 2022
SeaSpine’s New Distributors Drive Record Revenues
The company grew nearly 45% in 3Q22 on the strength of its new distribution partners and increased surgical volumes. Nov 04, 2022
Zimmer Biomet Momentum Leads to Guidance Raise
The company grew in the mid-single digits for 3Q22 when adjusting for currency headwinds and raised its 2022 revenue guidance. Nov 03, 2022
